Does QUIZARTINIB Cause Electrocardiogram qt prolonged? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Electrocardiogram qt prolonged have been filed in association with QUIZARTINIB (VANFLYTA). This represents 5.3% of all adverse event reports for QUIZARTINIB.
19
Reports of Electrocardiogram qt prolonged with QUIZARTINIB
5.3%
of all QUIZARTINIB reports
3
Deaths
4
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From QUIZARTINIB?
Of the 19 reports, 3 (15.8%) resulted in death, 4 (21.1%) required hospitalization.
Is Electrocardiogram qt prolonged Listed in the Official Label?
Yes, Electrocardiogram qt prolonged is listed as a known adverse reaction in the official FDA drug label for QUIZARTINIB.
What Other Side Effects Does QUIZARTINIB Cause?
Off label use (47)
No adverse event (40)
Death (32)
Platelet count decreased (27)
Nausea (25)
Disease progression (20)
Pyrexia (20)
Febrile neutropenia (19)
Product dose omission issue (18)
Infection (17)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which QUIZARTINIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?
QUIZARTINIB vs RABEPRAZOLE
QUIZARTINIB vs RACECADOTRIL
QUIZARTINIB vs RADIATION THERAPY
QUIZARTINIB vs RADIUM RA-223 DICHLORIDE
QUIZARTINIB vs RALOXIFENE